Patent US5670177A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5670177A Expired / Lapsed US ⏱️ 0.0 years remaining

Injectable NO/CO2 gaseous mixture

Assignee: LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
•
Filing: 1996-10-18
•
Granted: 1997-09-23
•
Expires: 2016-10-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for treating or preventing ischemia comprising administering to a patient by an intravascular route a gaseous mixture comprising nitric oxide (NO) and carbon dioxide (CO2), wherein the nitric oxide is present in an amount effective to treat or prevent ischemia. A gaseous mixture for treatment or prevention of ischemia comprising: (i) nitric oxide in an amount effective to prevent ischemia; and (ii) carbon dioxide.

Inventors

  • 👤 Robert Briend
  • 👤 Marie-Helene Renaudin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 22:05
CPC Classifications
A; A61; A61K; A61K33/00; A61P; A61P9/00; A61P9/10

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 27 words
A gaseous mixture for treatment or prevention of ischemia comprising: (i) nitric oxide in an amount effective to prevent ischemia; (ii) carbon dioxide; and (iii) nitrogen protoxide.
Claim 2
Dependent Claim 27 words
A gaseous mixture for treatment or prevention of ischemia comprising: (i) nitric oxide in an amount effective to prevent ischemia; (ii) carbon dioxide; and (iii) nitrogen protoxide.
Claim 3
Dependent Claim 21 words
The gaseous mixture of claim 1 wherein said gaseous mixture further comprises at least one of xenon, krypton, and their mixtures.
Claim 4
Dependent Claim 20 words
The gaseous mixture of claim 1, wherein said gaseous mixture comprises a concentration of NO between 1 and 100 ppm.
Claim 5
Dependent Claim 21 words
The gaseous mixture according to claim 1 wherein said gaseous mixture comprises a concentration of NO between 15 and 30 ppm.
Claim 6
Independent Claim 44 words
A method for treating or preventing ischemia comprising administering to a patient by an intravascular route a gaseous mixture comprising nitric oxide (NO) and carbon dioxide (CO 2 ), wherein said nitric oxide is present in an amount effective to treat or prevent ischemia.
Claim 7
Independent Claim 44 words
A method for treating or preventing ischemia comprising administering to a patient by an intravascular route a gaseous mixture comprising nitric oxide (NO) and carbon dioxide (CO 2 ), wherein said nitric oxide is present in an amount effective to treat or prevent ischemia.
Claim 8
Independent Claim 44 words
A method for treating or preventing embolism comprising administering to a patient by an intravascular route a gaseous mixture comprising nitric oxide (NO) and carbon dioxide (CO 2 ), wherein said nitric oxide is present in an amount effective to treat or prevent embolism.
Claim 9
Independent Claim 44 words
A method for treating or preventing embolism comprising administering to a patient by an intravascular route a gaseous mixture comprising nitric oxide (NO) and carbon dioxide (CO 2 ), wherein said nitric oxide is present in an amount effective to treat or prevent embolism.
Claim 10
Dependent Claim 23 words
The method according to claim 5, wherein said gaseous mixture further comprises at least one of nitrogen protoxide, xenon, krypton, and their mixtures.
Claim 11
Dependent Claim 20 words
The method according to claim 5 wherein said gaseous mixture comprises a concentration of NO between 1 and 100 ppm.
Claim 12
Dependent Claim 20 words
The method according to claim 5 wherein said gaseous mixture comprises a concentration of NO between 15 and 30 ppm.
Claim 13
Dependent Claim 14 words
The method according to claim 5 wherein said intravascular route is an intra-arterial route.
Claim 14
Dependent Claim 14 words
The method according to claim 5 wherein said intravascular route is an intracardial route.
Claim 15
Dependent Claim 14 words
The method according to claim 5 wherein said intravascular route is an intravenous route.

References Cited (Backward Citations)

WO1992010228A1 Cited
WO1994000180A1 Cited
WO1994022499A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-09-22 2001-03-24 2001-09-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-09-22 2005-03-24 2005-09-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-09-22 2009-03-24 2009-09-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag